These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9926068)

  • 1. Doxazosin for reboxetine-induced urinary hesitancy.
    Szabadi E
    Br J Psychiatry; 1998 Nov; 173():441-2. PubMed ID: 9926068
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful treatment of reboxetine-induced urinary hesitancy with tamsulosin.
    Kasper S; Wolf R
    Eur Neuropsychopharmacol; 2002 Apr; 12(2):119-22. PubMed ID: 11872327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Managing reboxetine-associated urinary hesitancy in a patient with major depressive disorder: a case study.
    Kasper S
    Psychopharmacology (Berl); 2002 Feb; 159(4):445-6. PubMed ID: 11823898
    [No Abstract]   [Full Text] [Related]  

  • 4. Tamsulosin as an effective treatment for reboxetine-associated urinary hesitancy.
    Demyttenaere K; Huygens R; Van Buggenhout R
    Int Clin Psychopharmacol; 2001 Nov; 16(6):353-5. PubMed ID: 11712624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary retention with reboxetine-fluoxetine combination in a young man.
    Benazzi F
    Can J Psychiatry; 2000 Dec; 45(10):936. PubMed ID: 11190365
    [No Abstract]   [Full Text] [Related]  

  • 6. Painful ejaculation and urinary hesitancy in association with antidepressant therapy: relief with tamsulosin.
    Demyttenaere K; Huygens R
    Eur Neuropsychopharmacol; 2002 Aug; 12(4):337-41. PubMed ID: 12126873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmaceutical review.
    O'Reilly P
    BJU Int; 2003 Aug; 92(3):330-1; author reply 331. PubMed ID: 12887496
    [No Abstract]   [Full Text] [Related]  

  • 8. Finasteride in benign prostatic hyperplasia.
    Verhamme KM; Bosch RJ; Sturkenboom MC
    N Engl J Med; 2004 Mar; 350(13):1359-61; author reply 1359-61. PubMed ID: 15049034
    [No Abstract]   [Full Text] [Related]  

  • 9. Reboxetine-induced hypomania.
    Vieta E; Colom F; Martínez-Arán A; Reinares M; Benabarre A; Corbella B; Gastó C
    J Clin Psychiatry; 2001 Aug; 62(8):655-6. PubMed ID: 11561941
    [No Abstract]   [Full Text] [Related]  

  • 10. Doxazosin for treating lower urinary tract symptoms compatible with benign prostatic obstruction: a systematic review of efficacy and adverse effects.
    MacDonald R; Wilt TJ; Howe RW
    BJU Int; 2004 Dec; 94(9):1263-70. PubMed ID: 15610102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Doksazozin "Cardura" in acute urinary retention caused by benign prostatic hyperplasia].
    Perepanova TS; Kamalov AA; Siniukhin VN; Gorokhnov AV; Khazan PL; Orlova EV
    Urologiia; 2001; (3):18-20. PubMed ID: 11505534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical treatment for urinary retention in rehabilitating elderly women: is it necessary?
    Hershkovitz A; Manevitz D; Beloosesky Y; Gillon G; Brill S
    Aging Clin Exp Res; 2003 Feb; 15(1):19-24. PubMed ID: 12841414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of reboxetine on human sleep architecture in depression: preliminary results.
    Farina B; Della Marca G; Mennuni G; Mazza S; De Risio S; Di Giannantonio M
    J Affect Disord; 2002 Sep; 71(1-3):273-5. PubMed ID: 12167528
    [No Abstract]   [Full Text] [Related]  

  • 14. Reboxetine-induced spontaneous ejaculation.
    O'Flynn R; Michael A
    Br J Psychiatry; 2000 Dec; 177():567-8. PubMed ID: 11102344
    [No Abstract]   [Full Text] [Related]  

  • 15. When you just can't go: my patient, a 63-year old stockbroker, recalled his experience with acute urinary retention.
    Consum Rep; 2009 Aug; 74(8):19. PubMed ID: 19821541
    [No Abstract]   [Full Text] [Related]  

  • 16. Alpha blocker therapy for children with dysfunctional voiding and urinary retention.
    Cain MP; Wu SD; Austin PF; Herndon CD; Rink RC
    J Urol; 2003 Oct; 170(4 Pt 2):1514-5; discussion 1516-7. PubMed ID: 14501648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Doxazosin-alpha-1-adrenergic antagonists drug in the long-term (3 years). Management of benign prostatic hyperplasia.
    Dutkiewicz S
    Mater Med Pol; 1996; 28(3):93-102. PubMed ID: 9167419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can alpha-blocker therapy be an alternative to biofeedback for dysfunctional voiding and urinary retention? A prospective study.
    Yucel S; Akkaya E; Guntekin E; Kukul E; Akman S; Melikoglu M; Baykara M
    J Urol; 2005 Oct; 174(4 Pt 2):1612-5; discussion 1615. PubMed ID: 16148665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative study of: long-term alpha-1-blocker, Doxazosin therapy versus surgery in the treatment of benign prostatic hyperplasia.
    Dutkiewicz S
    Mater Med Pol; 1995; 27(4):151-2. PubMed ID: 9000839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia.
    McConnell JD; Roehrborn CG; Bautista OM; Andriole GL; Dixon CM; Kusek JW; Lepor H; McVary KT; Nyberg LM; Clarke HS; Crawford ED; Diokno A; Foley JP; Foster HE; Jacobs SC; Kaplan SA; Kreder KJ; Lieber MM; Lucia MS; Miller GJ; Menon M; Milam DF; Ramsdell JW; Schenkman NS; Slawin KM; Smith JA;
    N Engl J Med; 2003 Dec; 349(25):2387-98. PubMed ID: 14681504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.